Max-Planck-Institute of Psychiatry
Max-Planck-Institute of Psychiatry
Munich, Bavaria, Germany1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Inflammation, Neuroinflammatory Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, depressive disorder, long COVID-19, lung disorder, major depressive disorder, mood disorder, nervous system disorder, pneumonia, psychiatric disorder, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not applicable | 2026-10-07 | NCT07197138 |